EU clearance decision in GTCR’s Zentiva deal gets published
( May 29, 2026, 08:07 GMT | Official Statement) -- MLex Summary: The text of a previous decision to approve US private equity firm GTCR's acquisition of Czech generic drug manufacturer Zentiva has been released by the European Commission. In March, the EU merger regulator cleared the deal unconditionally, saying the transaction had a limited impact on competition.The public version of the decision is attached. Case reference is M.12186. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.